🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study includes 3 parts: Parts A, B, and C. The purpose of this study i...
Status
Completed
Location
Pinnacle Research Group
Start Date
2023-04-17
Trial ID
NCT05827978
Treatments Being Tested
The primary objectives of this study are to evaluate the humoral immunogeni...
Status
Completed
Location
CEI -Centro de Estudios Infectológicos
Start Date
2022-06-06
Trial ID
NCT05415462
Treatments Being Tested
The primary goal of this study is to evaluate the safety and reactogenicity...
Status
Completed
Location
Accel Research Sites
Start Date
2022-10-14
Trial ID
NCT05585632
Treatments Being Tested
The primary objective of this study is to evaluate the safety, reactogenici...
Status
Completed
Location
Foothills Research Center
Start Date
2022-04-06
Trial ID
NCT05333289
Treatments Being Tested
The primary objectives of this study are to evaluate the safety and reactog...
Status
Completed
Location
Pinnacle Research Group, Llc
Start Date
2024-09-16
Trial ID
NCT06602024
Treatments Being Tested
The primary goal of this study is to evaluate the safety, reactogenicity, a...
Status
Completed
Location
Research Centers of America
Start Date
2022-05-13
Trial ID
NCT05375838
The purpose of this study is to evaluate the safety and efficacy of mRNA-10...
Status
Completed
Location
North Alabama Research Center, LLC
Start Date
2022-09-14
Trial ID
NCT05566639
Treatments Being Tested
The main purpose of the study is to evaluate the safety, reactogenicity, an...
Status
Completed
Location
CenExel RCA
Start Date
2023-05-15
Trial ID
NCT05868382
Treatments Being Tested
The main goal of this study is to evaluate the safety, reactogenicity, and ...
Status
Completed
Location
CenExel
Start Date
2022-05-24
Trial ID
NCT05397223
The study comprises 3 parts: Phase 1/2, Phase 2 Northern Hemisphere (NH), a...
Status
Completed
Location
Cognitive Clinical Trials - Phoenix
Start Date
2021-07-06
Trial ID
NCT04956575
Treatments Being Tested